| Stereochemistry | ACHIRAL |
| Molecular Formula | C11H10N2O2 |
| Molecular Weight | 202.2093 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC=CC(OC2=CNC(=O)N=C2)=C1
InChI
InChIKey=HJQILFPVRNHTIG-UHFFFAOYSA-N
InChI=1S/C11H10N2O2/c1-8-3-2-4-9(5-8)15-10-6-12-11(14)13-7-10/h2-7H,1H3,(H,12,13,14)
| Molecular Formula | C11H10N2O2 |
| Molecular Weight | 202.2093 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Originator
Approval Year
Sourcing
PubMed
Patents
Sample Use Guides
Mice - A single administration of MLR-1023 (Tolimidone) elicited a reduction in blood glucose levels, with a maximal response produced by a dose level of 30 mg/kg.
Route of Administration:
Oral
